Loading...
NPI 1811441751 · Milford, CT · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Atlantic Diagnostic Laboratories, LLC is a clinical medical laboratory provider located in Milford, Connecticut. This profile covers 14 Medicare and 38 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Atlantic Diagnostic Laboratories, LLC |
| Address | 20 Quirk Rd |
| City | Milford |
| State | CT |
| ZIP | 06460 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | August 9, 2016 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $6.2M |
| Medicare | $18.4K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
14 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 220 | $60 | $13.1K |
| 86481 | The lab analyst performs a test to evaluate an antigen response to certain tuberculosis (TB) antibodies by enumerating T cells that produce gamma interferon. | 10 | $100 | $1.2K |
| 86803 | Qualitative or Semiquantitative Immunoassays; Hepatitis C antibody | 50 | $10 | $670 |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 50 | $10 | $540 |
| 87340 | The lab analyst performs a test to detect hepatitis B surface antigen, also called HBsAg, using an immunoassay technique, such as EIA. | 50 | $10 | $470 |
| 86780 | The lab analyst performs an immunoassay to evaluate the patient’s serum for antibodies to Treponema pallidum, a spiral shaped bacteria called a spirochete, that causes syphilis. | 30 | $10 | $430 |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 50 | $10 | $410 |
| 87521 | A lab tests a patient’s specimen to provide a definitive diagnosis of hepatitis C by amplified probe technique. | 10 | $30 | $370 |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 20 | $20 | $360 |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 30 | $10 | $230 |
Showing 1–10 of 14
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
38 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 160,010 | $30 | $5.3M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 1,650 | $70 | $120.4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3,930 | $20 | $86.4K |
| 86328 | The lab analyst performs a single–step immunoassay to qualitatively or semiquantitatively evaluate the patient’s specimen for antibodies to the severe acute respiratory syndrome coronavirus 2… | 1,850 | $40 | $79.6K |
| 86481 | The lab analyst performs a test to evaluate an antigen response to certain tuberculosis (TB) antibodies by enumerating T cells that produce gamma interferon. | 930 | $60 | $59.2K |
| 86803 | Qualitative or Semiquantitative Immunoassays; Hepatitis C antibody | 3,980 | $10 | $47.8K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 1,410 | $30 | $42.2K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 1,400 | $30 | $41.9K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 4,400 | $10 | $39.6K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 1,700 | $20 | $35.6K |
Showing 1–10 of 38
How this provider's Medicaid billing volume and revenue compare to other Connecticut providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Connecticut median
38 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 17 | 30 | 5,480 | $60 | $581.1K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 30 | 50 | 4,240 | $30 | $410.4K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 30 | 50 | 4,240 | $30 | $409.9K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 1 | 60 | 9,020 | $20 | $324.9K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 15 | 20 | 1,770 | $30 | $278.8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 31 | 50 | 4,960 | $20 | $273.9K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 21 | 30 | 4,170 | $10 | $142.7K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 32 | 50 | 2,470 | $10 | $137.9K |
| 87660 | The lab analyst performs a test for Trichomonas vaginalis using direct nucleic acid probe technique. | 17 | 20 | 1,970 | $20 | $88.9K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 23 | 40 | 7,230 | $10 | $80.2K |
Showing 1–10 of 38
Other providers in the same ZIP code as Atlantic Diagnostic Laboratories, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Bridges Healthcare Inc. | CT | Adult Mental Health Clinic/Center | $0 | $18.8M |
| Totality Home Health Care Agency, LLC | CT | Home Health Agency | $0 | $18.4M |
| Bridgeport Hospital | CT | General Acute Care Hospital | $0 | $15.6M |
| Milford Pediatric Group, PC | CT | Specialist | $0 | $10.4M |
| Milford Hospital, Inc | CT | General Acute Care Hospital | $0 | $3.3M |
| Dlv LLC | CT | Pediatric Dentistry | $0 | $3.2M |
| Fairfield Pediatric Dentistry | CT | Pediatric Dentistry | $0 | $3.2M |
| Genesis Medica LLC | CT | Internal Medicine Physician | $0 | $3M |
| Milford Board Of Education | CT | Local Education Agency (LEA) | $0 | $2.8M |
| Southern Connecticut Behavioral Health LLC | CT | Clinical Social Worker | $0 | $2.2M |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.